Login / Signup
Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis.
Kazuhiko Kato
Tatsuhiro Yaginuma
Arisa Kobayashi
Akio Nakashima
Ichiro Ohkido
Takashi Yokoo
Published in:
Journal of bone and mineral metabolism (2024)
The study showed long-term suppression of TRACP-5b and BAP levels and sustaining BMD after denosumab administration over an extended period in patients undergoing hemodialysis.
Keyphrases
</>
bone mineral density
patients undergoing
postmenopausal women
body composition
peritoneal dialysis
end stage renal disease
chronic kidney disease